Deutsche Bank analyst George Hill downgrades McKesson (NYSE:MCK) from Buy to Hold.
Oragenics Awarded A $250,000 Grant From The National Institute Of General Medical Sciences For The Continued Research And Development Of Lantibiotics
Oragenics, Inc. (NYSE:OGEN) (“Oragenics” or the “Company”) today announced that it was awarded a small business innovation research grant in the amount of $250,000 (“Computer-aided Design
